Research Article
The Effects of Pitavastatin on Nuclear Factor-Kappa B and ICAM-1 in Human Saphenous Vein Graft Endothelial Culture
Table 6
Comparison of NF-κB mRNA expression levels between groups.
| Comparison Groups | P Value |
| Control x Low Dose Pitavastatin | 0.001 | Control x High Dose Pitavastatin | 0.002 | Control x TNF-α | 0.001 | Control x Low Dose Pitavastatin + TNF-α | 0.001 | Control x High Dose Pitavastatin + TNF-α | 0.001 | Control x DMSO | 1.000 | Low Dose Pitavastatin x High Dose Pitavastatin | 0.002 | Low Dose Pitavastatin x TNF-α | 0.001 | Low Dose Pitavastatin x Low Dose Pitavastatin + TNF-α | 0.001 | Low Dose Pitavastatin x High Dose Pitavastatin + TNF-α | 0.001 | Low Dose Pitavastatin x DMSO | 0.001 | High Dose Pitavastatin x TNF-α | 0.002 | High Dose Pitavastatin x Low Dose Pitavastatin + TNF-α | 0.002 | High Dose Pitavastatin x High Dose Pitavastatin + TNF-α | 0.002 | High Dose Pitavastatin x DMSO | 0.002 | Low Dose Pitavastatin + TNF-αx TNF-α | 0.205 | Low Dose Pitavastatin + TNF-αx High Dose Pitavastatin + TNF-α | 0.673 | Low Dose Pitavastatin + TNF-αx DMSO | 0.001 | High Dose Pitavastatin + TNF-αx TNF-α | 0.205 | High Dose Pitavastatin + TNF-αx DMSO | 0.001 | TNF-α x DMSO | 0.001 |
|
|
NF-κB, nuclear factor-kappa B; TNF-α, tumor necrosis factor-α; DMSO, dimethyl sulfoxide.
|